This is the place for the latest information about our work here at Glaucoma Research Foundation and for current events in the world of eye health. All breakthroughs and insights are made possible through the dedication of researchers, and through the continued financial support and active involvement of the community.

The 2022 Weston Lecture: Ahmara Gibbons Ross, MD, PhD

“Neuroprotection: A New Path for Glaucoma Patients” was the topic of the 2022 Weston Family Lecture presented virtually on October 27, 2022.

The What, Why, When, and How of Planned Giving

This one-hour recorded webinar was first presented on October 14, 2022 by Glaucoma Research Foundation.

The Power of Connection: Peer Support for Glaucoma Patients and Their Loved Ones

Whether you’ve recently been diagnosed with glaucoma or are learning how to cope, connecting with others can be helpful and powerful.

Tips To Help a Child With Glaucoma in the Classroom

If your child has glaucoma or a child in your classroom has it, you may wonder how the condition affects their ability to learn in school.

Can Glaucoma Affect Contrast Sensitivity?

Contrast sensitivity is the eyes’ ability to identify an object not clearly defined from its background.

Santen Receives FDA Approval for Omlonti for Primary Open-Angle Glaucoma

The new glaucoma eye drop medication increases drainage through the eye’s conventional outflow pathways via a unique pharmacological action.

Can Diet Affect Glaucoma?

Although no studies prove a connection between specific foods and glaucoma, it’s safe to assume that your diet and your overall health can affect the disease.

Tips To Minimize the Side Effects of Glaucoma Medications

If you are experiencing side effects from your glaucoma medications, learn what you can do to reduce or eliminate them.

Neurodegeneration Explained

What is neurodegeneration? And how will discoveries related to it affect people with glaucoma?

Catalyst for a Cure: Meet the New Team of Investigators

The Catalyst for a Cure Initiative to Prevent and Cure Neurodegeneration.

Fourth Catalyst for a Cure Tackles Neurodegeneration

Made possible by visionary donors, Glaucoma Research Foundation’s latest research initiative targets the shared roots of conditions that occur when neurons deteriorate and die.

Meet Renaissance Innovators Ted and Melza Barr

The Catalyst for a Cure Initiative to Prevent and Cure Neurodegeneration is the inspiration of longtime GRF supporters Ted and Melza Barr.

Catalyst for a Cure: A Synergistic Approach to Scientific Research

Dr. John G. Flanagan discusses recent discoveries that could cure glaucoma based on key research accomplishments from 20 years of Catalyst for a Cure.

Study: Black Glaucoma Patients Six Times More Likely to Have Advanced Vision Loss than White Patients

A study by US researchers compared levels of sight loss in patients with a new diagnosis of primary open-angle glaucoma.

“Solving Neurodegeneration” White Paper Publication Results from Innovative Research Collaboration

Research paper summarizes the most important common elements that characterize progression in neurodegeneration and hope for new therapies to help patients with these devastating diseases.

Glaukos Receives FDA 510(k) Clearance of the iStent Infinite MIGS Device

MIGS founder announces the first-ever micro-invasive implantable device for standalone glaucoma treatment.

Can Working on a Computer Affect My Glaucoma?

No strong evidence suggests excessive use of digital technology is a glaucoma risk factor. However, prolonged computer, tablet, cell phone, and other digital device use can lead to eye strain.

Endoscopic Laser Treatment

Endoscopic laser surgery is used to treat both open-angle and angle-closure glaucoma.

Protecting Retinal Ganglion Cells

This article summarizes published findings from Catalyst for a Cure (CFC1) research scientists and subsequent discoveries by Dr. Rebecca Sappington’s lab at Vanderbilt and Wake Forest.

I’m Allergic to My Glaucoma Eye Drops. Is This Common?

While it’s uncommon for people to have an allergic reaction to eye drops, it can happen.

The Robert N. Shaffer Glaucoma Lecture

Since 1980, the American Academy of Ophthalmology has presented a named lecture in honor of pioneering glaucoma specialist Robert N. Shaffer, MD in conjunction with their annual meeting.

When People With Glaucoma Should Avoid Allergy and Decongestant Medications

Some allergy medications include ingredients that can cause pupil dilation resulting in a condition called acute angle-closure glaucoma.

What Is Considered Normal Eye Pressure?

Eye pressure can vary hourly, daily, and weekly. Measuring your intraocular pressure (IOP) during eye exams provides an important indication of your eye health.

Can Exercise Lower Eye Pressure?

Exercise for glaucoma patients can be beneficial. Research has shown that regular exercise lowers intraocular pressure (IOP) in glaucoma patients.

Pilot Project Grants Fill Critical Gap

Pilot project grants support new and promising ideas in the field of glaucoma research.